issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged share capital (the “Share Purchase”) at the price of INR 36 per share. The Company would

by its indirect subsidiary Indorama Netherlands B.V. (“INBV”) of 83,000,000 newly issued shares in Indo Rama Synthetics (India) Limited (“IRSL”), equaling to approximately 31.79% of IRSL’s enlarged

or 22.90% over the same period of last year of which hospital revenues totally raised by 10.16% along with the enlarged customer base of Subsidiary (AMARC) showing 15.67% of revenues’ growth. In

;                 - For bond series ECF262A: increase the interest rate to 7.70 percent per year from 7.60 percent per year.                   (3) Granting approval for modifying the interest payment schedule from

year, the Company has not yet earned income from Excellence Center (New Building) planned to official grand opening in the following year of February 2018) along with the enlarged customer base of the

repayment, refinancing, negotiating relief, or modifying debt restructuring agreements with financial institutions. The SEC requires that the bondholders’ representative analyzes the benefits and

date by additional three years. This would constitute a deferral of debt repayment, including postponing or modifying the debt payment schedule, and should not be considered an event of default under

are allowed to also inform the SEC of the names of foreign business operators instead of only the names of the foreign personnel as previously required; 2. Modifying the requirements for notifying the

at least on a quarterly basis;5.  Modifying consideration procedures of underlying indices, management strategies, and disclosure requirements for inbound foreign ETFs to be in line with those

percent per year.                (4) Granting an approval for modifying the interest payment schedule from quarterly payments to semi-annual payments;            (5) Approving the cancellation of the bond